Amneal Pharmaceuticals (AMRX) Cash & Current Investments (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted Cash & Current Investments of $127.6 million for Q2 2026, down 35.42% on a QoQ basis from $197.7 million in Q1 2026, and up 78.4% year-over-year from $71.5 million in Q2 2025.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) Cash & Current Investments (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals has reported Cash & Current Investments for 10 years, with the latest figure at $127.6 million in Q2 2026.
- On a quarterly basis, Cash & Current Investments rose 78.4% year-over-year to $127.6 million in Q2 2026; TTM through Jun 2026 was $127.6 million, a 78.4% increase from a year earlier, with the FY2025 full-year figure at $282.0 million, up 155.11% from the prior year.
- Cash & Current Investments was $127.6 million for Q2 2026 at Amneal Pharmaceuticals, down from $197.7 million in the prior quarter.
- The five-year high for Cash & Current Investments was $282.0 million in Q4 2025, with the low at $26.0 million in Q4 2022.
- Average Cash & Current Investments over 5 years is $114.6 million, with a median of $91.8 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2023: Cash & Current Investments tumbled 89.52% in 2022, then jumped 252.41% in 2023.
- Over 5 years, Cash & Current Investments stood at $26.0 million in 2022, then surged by 252.41% to $91.5 million in 2023, then gained by 20.77% to $110.6 million in 2024, then soared by 155.11% to $282.0 million in 2025, then sank by 54.74% to $127.6 million in 2026.
- The last three Cash & Current Investments figures came in at $127.6 million (Q2 2026), $197.7 million (Q1 2026), and $282.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | 3.66 Bn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | 886.50 Mn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | 171.67 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | 127.64 Mn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | 1.84 Bn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | 360.25 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | 142.75 Mn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | 290.12 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | 41.25 Mn |
| 10 | NutriBand | 94.45 Mn | 91.03 Mn | 181,874.00 | 3.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 127.64 Mn |
| Mar 31, 2026 | 197.66 Mn |
| Dec 31, 2025 | 282.03 Mn |
| Sep 30, 2025 | 201.25 Mn |
| Jun 30, 2025 | 71.54 Mn |
| Mar 31, 2025 | 59.19 Mn |
| Dec 31, 2024 | 110.55 Mn |
| Sep 30, 2024 | 74.01 Mn |
| Jun 30, 2024 | 43.77 Mn |
| Mar 31, 2024 | 46.52 Mn |
| Dec 31, 2023 | 91.54 Mn |
| Sep 30, 2023 | 86.93 Mn |
| Jun 30, 2023 | 109.28 Mn |
| Mar 31, 2023 | 144.67 Mn |
| Dec 31, 2022 | 25.98 Mn |
| Sep 30, 2022 | 87.34 Mn |
| Jun 30, 2022 | 91.98 Mn |
| Mar 31, 2022 | 210.48 Mn |
| Dec 31, 2021 | 247.79 Mn |
| Sep 30, 2021 | 302.66 Mn |
API Access
Amneal Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();